CBD May Inhibit Replication of SARS-CoV-2 in Human Lung Cells

 
virus.jpg

A study conducted by researchers in Chicago shows that a specific cannabis compound effectively slowed the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells. 

Coronavirus 19 (COVID-19), the disease that has disrupted the entire globe for over a year, is caused by SARS-CoV-2. 

Marsha Rosner, University of Chicago in Illinois researcher, and her colleagues reported on their discoveries March 10 in a pre-print version of the research paper “Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response.”

Click Here to read the rest of the article.

CERTIFIEDCBDCONSULTANT_LOGO_Transparent.png

Now is the time to be a leader in the CBD industry. Get Certified!

 
Joe Medrano, ARM, CCBDCcorona virus, covid19, cbd educationComment